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Abstract
AIM: To determine whether there is a correlation be-
tween the location of the lesion and endoscopic sub-
mucosal dissection (ESD) outcome.
METHODS: From January 2008 to December 2010, 
ESD of 1443 gastric tumors was performed. En bloc  
resection rate, complete resection rate, procedure time 
and complication rate were analyzed according to the 
tumor location.
RESULTS: The rates of en bloc  resection and complete 
resection were 91% (1318/1443) and 89% (1287/1443), 
respectively. The post-ESD bleeding rate was 4.3%, 
and perforation rate was 2.7%. Tumors located in the 
upper third of the stomach were associated with a 
longer procedure time and significantly higher rates 
of incomplete resection, piecemeal resection, and 
perforation than tumors below the upper third of the 
stomach. Posterior wall lesions had significantly longer 
procedure times and higher rates of incomplete resec-
tion and piecemeal resection than lesions in other lo-
cations. In multivariate analysis, posterior wall lesions 
and upper third lesions were significantly associated 
with incomplete resection and perforation, respectively. 
In post-ESD bleeding analysis, location was not a sig-
nificant related factor.
CONCLUSION: More advanced endoscopic techniques 
are required during ESD for lesions located in the up-
per third or posterior wall of the stomach to decrease 
complications and improve therapeutic outcomes.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
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Core tip: Location of the tumor is one of the most im-
portant clinical factors for complete resection and com-
plications of endoscopic submucosal dissection (ESD) 
for early gastric cancer. Nonetheless, few studies have 
evaluated clinicopathologic outcomes of ESD accord-
ing to the subdivision of tumor location. Based on our 
data, posterior wall lesions and upper third lesions 
were significantly associated with incomplete resection 
and perforation, respectively. Therefore, endoscopists 
should recognize the need for more advanced endo-
scopic techniques when performing ESD for lesions lo-
cated in the upper third or posterior wall of the stom-
ach to decrease the rate of serious complications and 
improve clinical outcomes.
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INTRODUCTION
Advances in diagnostic technology and the increasing 
prevalence of  screening programs have increased the 
rate of  early gastric cancer (EGC) detection. EGCs 
that are confined to the mucosa and lack lymph node 
metastasis can be cured by endoscopic resection, such 
as endoscopic mucosal resection (EMR) or endoscopic 
submucosal dissection (ESD)[1-4]. Compared with EMR, 
ESD may achieve complete resection not only of  larger 
lesions but also of  ulcerative lesions. In addition, ESD 
allows for a precise histological assessment of  resected 
specimens and may reduce the risk of  residual disease 
and local recurrence[5].
The factors affecting successful ESD include several 
characteristics of  lesions such as location, presence of  
ulceration and histology[6,7]. In a recent multicenter study, 
scarred lesions, undifferentiated lesions and lesions lo-
cated in the upper third required more advanced ESD 
techniques, because the complete resection rate is lower 
with these lesions than with other lesions[7]. In addition, 
the location of  the tumor is one of  the most important 
clinical factors for whether or not complete resection is 
possible or whether or not complication occurs. How-
ever, few studies have evaluated clinicopathologic out-
comes of  ESD according to the subdivision of  tumor 
location in the longitudinal portions of  the stomach and 
cross-sectional circumference divided into four equal 
parts. Therefore, we conducted this study to evaluate the 
level of  difficulty of  the procedure and clinicopathologic 
outcomes according to the tumor location.
MATERIALS AND METHODS
Patients
We analyzed 1319 patients with 1443 lesions who under-
went ESD for gastric tumors at Yonsei University Health 
Care Center between January 2008 and December 2010.
Endoscopy with standard upper gastrointestinal en-
doscopes (GIF Q260 and H260, Olympus, Japan), chro-
moendoscopy with indigo carmine, and biopsies of  the 
lesions with standard biopsy forceps (FB-21K-1; Olym-
pus, Japan) were initially performed to determine the 
feasibility of  ESD. Endoscopic ultrasonography (EUS) 
with radial scanning echoendoscopes (EG-3679URK, 
Pentax, Japan and GF-UE260, Olympus, Japan) was 
performed in case of  carcinoma to evaluate the depth 
of  invasion. Patients with lesions confirmed to be gastric 
cancer underwent abdominal computed tomography 
(CT) scans to determine if  lymph node or distant metas-
tasis was present. For this study, the endoscopic findings 
of  EGC were classified as elevated (types Ⅰ or Ⅱa), flat 
(type Ⅱb), depressed (types Ⅱc, Ⅱc+Ⅲ, or Ⅱa+Ⅱc) or 
mixed (types Ⅱa+Ⅱb, Ⅱb+Ⅱc, Ⅱa + Ⅱc, Ⅲ+Ⅱa or 
Ⅲ+Ⅱb).
Gastric tumor lesions were classified according to 
their location in the upper, middle, and lower thirds of  
the stomach, and also to location in the cross-sectional 
circumference divided into four equal parts (anterior 
wall, posterior wall, lesser curvature or greater curva-
ture).
Eligibility criteria for ESD were as follows: (1) dif-
ferentiated adenocarcinoma (well- to moderately-differ-
entiated tubular adenocarcinoma) or dysplasia confirmed 
histologically by forceps biopsy; (2) depth of  invasion 
limited to the mucosa or submucosa (≤ 500 μm pen-
etration into the submucosa) as determined by EUS; (3) 
lesions without ulceration, regardless of  size, or 30 mm 
or less in size with ulceration; or (4) undifferentiated ad-
enocarcinoma or intramucosal cancer without ulcer find-
ings ≤ 20 mm in size[8].
Endoscopic resection
All procedures were performed by an attending gastro-
enterologist, and five attending physicians were involved 
in the procedures. All ESDs were performed under 
conscious sedation using intravenous propofol or mid-
azolam. Vital signs were continuously monitored during 
the procedure. After identifying the target lesion, mark-
ing dots were made circumferentially about 5 mm lateral 
to the margin of  the lesion using a needle knife (KD-10Q, 
Olympus, Japan) or argon plasma coagulation (ERBE 
Elektromedizin, Germany). Epinephrine (1:10000 dilu-
tion) was then injected submucosally around the lesion, 
and an initial short incision was made in the mucosa with 
a needle knife to allow submucosal insertion of  the tip 
of  an insulation-tipped (IT) knife (KD-611L, Olympus, 
Japan). Circumferential mucosal cutting was performed 
outside the marking dots, and an additional submucosal 
injection was carried out. Finally, direct dissection of  the 
submucosal layer was performed, and endoscopic hemo-
stasis with specialized hemostatic forceps (FD-410LR, 
Olympus, Japan) was performed when needed.
Histologic evaluation of resection efficacy
All resected specimens were systematically sectioned at 2 
mm intervals centered on the part of  the lesion closet to 
the margin and the site of  the deepest invasion. Histolog-
ical assessment was based on the Vienna classification[9].
Final pathologic diagnoses were classified as low 
grade dysplasia (LGD), high grade dysplasia (HGD), dif-
ferentiated EGC, and undifferentiated EGC.
Outcome measures
Patient data, including patient age, gender, previous 
medication history, the size, number and location of  
lesions, procedure start and end times, endoscopic find-
ings, pathology, and complications, were collected.
Complete resection of  en bloc resected tumors was 
defined as the lateral and vertical margins being free of  
tumor cells on histologic examination. Complete resec-
tion of  tumors resected in a piecemeal fashion was de-
fined as complete removal of  the entire lesion, including 
sufficient tumor-free margins after perfect reconstruc-
tion of  all pieces.
Procedure time was defined as the time from mark-
ing to complete removal, including the time required 
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Table 1  Baseline characteristics of gastric tumors  n  (%)
for hemostasis. Complication data included whether a 
complication occurred and details regarding bleeding, 
perforation and other factors related to the type of  
complication.
Clinicopathologic evaluation
To identify factors affecting the success of  ESD, we ana-
lyzed lesion characteristics, procedure, and the procedure 
result. Analyzed lesion characteristics included the pres-
ence of  ulceration, macroscopic morphology, size and 
location of  the tumor.
Procedure results were analyzed for curability. Resec-
tion was deemed complete when removal was achieved 
with tumor-free lateral and vertical margins and there 
was no lymphovascular involvement or lymph node 
metastasis. Incomplete resection was defined as any re-
section that did not meet the curative criteria described 
above.
Follow-up
Endoscopic surveillance by esophagogastroduodenos-
copy (EGD) was performed 3, 6, 12, and 24 mo after 
ESD for EGC to exclude local recurrence, as well as 
synchronous, and metachronous lesions. After 24 mo, 
EGD was carried out annually. Moreover, abdominal CT 
scans were performed every 6 mo for the first year and 
annually thereafter, to detect lymph node or distant me-
tastasis. In cases with adenomas, endoscopic surveillance 
by EGD was scheduled for 3, 12, and 24 mo after ESD.
Statistical analysis
The data were analyzed using Pearson’s χ 2 test, unpaired 
t-test, Fisher’s exact test, and the Mann-Whitney U test. 
P values < 0.05 were considered significant. To identify 
related risk factors for complications and complete re-
section, predictors with P values < 0.05 in the univariate 
analysis were included in a backward, stepwise multiple 
logistic regression model. All data analyses were con-
ducted using a statistical software package (SPSS version 
18.0, Chicago, IL, United States).
RESULTS
Gastric tumor characteristics
During the study period, ESD was performed in 1319 
patients with 1443 gastric tumors. Baseline clinicopatho-
logic characteristics of  the gastric tumors and the clinical 
outcomes of  ESD are shown in Table 1. Mean age was 
63.0 ± 9.4 years. The lesions consisted of  733 (50.8%) 
EGCs and 710 (49.2%) dysplastic lesions. Submucosal 
invasion occurred in 7.3% of  cases. Mixed-type endo-
scopic morphology was the most common (63.4%). 
With respect to size and location, tumors less than 20 
mm in size (71.7%), those located in the lower third 
(85.4%) and those located in the lesser curvature (33.3%) 
were most common. The mean tumor size was 15.72 
± 8.81 mm. The mean procedure time was 61.8 ± 47.0 
min. The complete resection rate was 89% (1287/1443), 
and the en bloc resection rate was 91.3% (Table 1). The 
post-ESD bleeding rate was 4.3%, and the perforation 
rate was 2.7%. Most cases of  bleeding (60/63) were 
treated by endoscopic hemostasis such as hemoclipping, 
argon plasma coagulation or epinephrine injection. Two 
cases were treated by angiographic embolization. Only 
one case required surgery for bleeding control.
Around half  of  all perforation cases (20/39) were 
minute or micro-perforations, while the remaining ones 
were overt perforations. Only two such cases required 
surgery. All other cases were treated by conservative 
care. There was no mortality in the present study.
Endoscopic outcomes according to the location
We compared the clinical outcomes of  ESD in relation 
to detailed tumor location. Upon division into upper 
third and other lesions, the upper third lesion group had 
significantly higher percentages of  incomplete resections 
(19.4% vs 10.2%, P = 0.005) and piecemeal resections 
(15.3% vs 8.2%, P = 0.015) compared with other tumor 
locations. Additionally, upper third lesions required a 
longer procedure time (90.51 min vs 59.71 min, P < 0.001) 
and were associated with a higher perforation rate (9.2% 
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Characteristic Value
Gender (female:male)     1:2.18 (454:989) 
Age, yr, mean ± SD 63.0 ± 9.4
Tumor size, mm
   < 20 1034 (71.7)
   ≥ 20   409 (28.3)
Macroscopic appearance
   Elevated   310 (21.5)
   Flat 128 (8.9)
   Depressed   90 (6.2)
   Mixed   915 (63.4)
Ulcer   71 (4.9)
Invasion depth
   Mucosa   612 (42.4) 
   Submucosa 106 (7.3) 
LocationⅠ
   Lower third 1233 (85.4)
   Middle third 112 (7.8)
   Upper third   98 (6.8)
Location Ⅱ
   Anterior wall   294 (20.4)
   Lesser curvature   481 (33.3)
   Posterior wall   405 (28.1)
   Greater curvature   263 (18.2)
Histology
   Low grade dysplasia   534 (37.0)
   High grade dysplasia   176 (12.2)
   Differentiated EGC   655 (45.4)
   Undifferentiated EGC   78 (5.4)
Procedure time, min     61.8 (± 47.0) 
Curability 
   Complete resection 1287 (89.0)
   Incomplete resection   156 (11.0)
Resectability
   En bloc 1318 (91.3)
   Piecemeal 125 (8.7)
Perforation   39 (2.7)
Post-ESD bleeding   63 (4.3)
EGC: Early gastric cancer; ESD: Endoscopic submucosal dissection.
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Table 4  Multivariate analysis for incomplete resection
Table 3  Comparison of the posterior wall and non-posterior 
wall groups  n  (%)
Table 2  Comparison of the upper third and non-upper third 
groups  n  (%)
vs 2.2%) (Table 2). There was no significant difference in 
the frequency of  post-ESD bleeding.
After dividing location according to posterior wall 
and other lesions, the posterior wall lesion group had a 
significantly longer procedure time (69.41 min vs 58.84 
min, P < 0.001) and higher rates of  incomplete resec-
tions (14.8% vs 9.2%, P = 0.002) and piecemeal resec-
tions (11.6% vs 7.5%, P = 0.013) than lesions in other 
locations (Table 3). There was no significant difference 
in the frequency of  post-ESD bleeding or perforation 
between the two groups.
Factors related to incomplete resection and 
complications
We analyzed the factors associated with complete resec-
tion complications of  ESD such as perforation or bleed-
ing. In univariate analyses, lesion size larger than 20 mm, 
upper third location, posterior wall location, carcinoma 
and procedure time longer than 60 min were significantly 
related to incomplete resection. In multivariate analysis, 
lesion size larger than 20 mm, posterior wall location, 
carcinoma and procedure time longer than 60 min were 
significantly related to incomplete resection (Table 4).
In addition, univariate predictors of  perforation were 
lesion size larger than 20 mm, upper third location, pro-
cedure time longer than 60 min and piecemeal resection. 
In multivariate analysis, upper third location, procedure 
time longer than 60 min and piecemeal resection were 
statistically significantly related to perforation (Table 5).
Moreover, univariate predictors of  post-ESD bleed-
ing were lesion size larger than 20 mm, procedure time 
longer than 60 min and piecemeal resection. In multi-
variate analysis, procedure time longer than 60 min and 
piecemeal resection were statistically significantly related 
to post-ESD bleeding (Table 6).
DISCUSSION
ESD has been widely accepted as an effective and safe 
treatment for gastric tumors[5,10]. To summarize previous 
studies, it is believed that the location of  a lesion affects 
both the completeness of  resection and whether compli-
cations are likely to occur[6,7,11-14]. These previous studies 
analyzed tumor location which is anatomically divided 
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Upper third Non-upper 
third
P  value
Tumor size, mm 
   < 20 70 (71.4)   964 (71.7)    0.520
   ≥ 20 28 (28.6)   381 (28.3) 
Ulcer 2 (2.0)   69 (5.1)    0.172
Pathology 
   Dysplasia 45 (45.9)   665 (49.4)    0.501
   Carcinoma 53 (54.1)   680 (50.6) 
Curability
   Incomplete resection 19 (19.4)   137 (10.2)    0.005
   Complete resection 79 (80.6) 1208 (89.8) 
Resectability
   En bloc 83 (84.7) 1235 (91.8)    0.015
   Piecemeal 15 (15.3) 110 (8.2) 
Procedure time, min, mean ± SD 90.51 ± 58.06 59.71 ± 45.46 < 0.001
Perforation 9 (9.2)   30 (2.2) < 0.001
Post-ESD bleeding 4 (4.1)   57 (4.2)    0.600
ESD: Endoscopic submucosal dissection.
Posterior wall Non-posterior 
wall
P  value 
Tumor size, mm 
   < 20 278 (68.6) 756 (72.8)    0.065
   ≥ 20 127 (31.4) 282 (27.2) 
Ulcer 21 (5.2) 50 (4.8)    0.771
Pathology 
   Dysplasia 216 (53.3) 494 (47.6)    0.053
   Carcinoma 189 (46.7) 544 (52.4) 
Procedure time, min, mean ± SD 69.41 ± 52.55 58.84 ± 44.39 < 0.001 
Curability
   Incomplete resection   60 (14.8) 96 (9.2)    0.002
   Complete resection 345 (85.2) 942 (90.8) 
Resectability
   En bloc 358 (88.4) 960 (92.5)    0.013
   Piecemeal   47 (11.6) 78 (7.5) 
Perforation 14 (3.5) 25 (2.4)  0.27
Post-ESD bleeding 17 (4.2) 44 (4.2)    0.552
ESD: Endoscopic submucosal dissection.
Univariate analysis Multivariate analysis
OR (95%CI) P  value OR (95%CI) P  value
Tumor size, mm 
   < 20 1 (reference)
   ≥ 20 2.144 
(1.526-3.011)
< 0.001 1.846 
(1.283-2.654)
   0.001
Ulcer
   - 1 (reference)
   + 1.210 
(0.589-2.485) 
   0.604
SM invasion 
   - 1 (reference)
   + 1.828 
(0.811-4.119)
   0.146
Location 
   Non-upper third 1 (reference)
   Upper third 2.12 
1(1.247-3.607)
   0.006 1.576 
(0.882-2.814)
   0.124
Location 
   Non-posterior wall 1 (reference)
   Posterior wall 1.707 
(1.208-2.410)
   0.002 1.687 
(1.163-2.449)
   0.006
Pathology
   Dysplasia 1 (reference)
   Carcinoma 4.921 
(3.240-7.475)




   < 60 1 (reference)
   ≥ 60 2.494 
(1.772-3.509)
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Table 6  Multivariate analysis for post-endoscopic submucosal 
dissection bleeding
Table 5  Multivariate analysis for perforation
into three portions (upper, middle, and lower thirds) as 
a factor related to the clinical outcomes of  ESD. Many 
studies reported that upper third location was associated 
with incomplete resection, longer procedure time and a 
higher rate of  perforation[7,11,12]. However, even among 
tumors located in the same thirds of  the stomach, the 
difficulty of  the procedure and the clinical outcomes 
may be different according to the cross-sectional circum-
ference, which is divided into four equal parts.
In our study, after dividing the upper third lesions 
from other lesions, it was found that the upper third 
lesion group had significantly higher percentages of  in-
complete resections (19.4% vs 10.2%) and piecemeal re-
sections (15.3% vs 8.2%), longer procedure time (91 min 
vs 60 min) and a higher perforation rate (9.2% vs 2.2%). 
Furthermore, we analyzed clinical outcomes between 
posterior wall lesions and non-posterior lesions. The 
posterior wall lesion group had significantly longer pro-
cedure times and more frequent piecemeal and incom-
plete resections, which are likely explained in part by the 
difference in technical difficulty and poor visual field.
In previous studies, procedure time during ESD be-
came longer as tumor locations became higher[7,15]. In 
addition, longer procedure time was needed for tumors 
located in the posterior wall[15]. These findings were 
consistent with our study results. As longer procedure 
times have been shown to be associated with increased 
risks of  complications[16,17], we attributed the relationship 
between tumor location and complications to the longer 
procedure time of  ESD for gastric tumors in the upper-
third or the posterior wall of  the stomach. As mentioned 
above, prolonged procedure time in cases involving the 
upper-third or the posterior wall location was caused 
primarily by technical difficulties and a poor visual field. 
During ESD for gastric tumors in the upper-third of  
the stomach, endoscopists cannot let the knife encroach 
on the submucosal layer beneath the tumor, and cannot 
control the direction and depth well adhering to the dis-
section plan[7]. Along these lines, the worse outcomes 
after ESD for those lesions in this study were also con-
sistent with earlier studies that demonstrated lower rates 
of  en bloc and curative resections in lesions of  the upper 
portion of  the stomach[6,7,12].
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Univariate analysis Multivariate analysis
OR (95%CI) P  value OR (95%CI) P  value
Tumor size, mm
   < 20 1 (reference)
   ≥ 20 2.470 
(1.304-4.678)
   0.006 1.574 
(0.807-3.071)
   0.183
Ulcer
   - 1 (reference)
   + 1.637 
(0.492-5.451) 
   0.422
SM invasion 
   - 1 (reference)
   + 1.041 
(0.238-4.550)
   0.957
Location 
   Non-upper third 1 (reference)
   Upper third 4.433 
(2.042-9.623)
< 0.001 2.783 
(1.138-6.803)
   0.025
Location 
   Non-posterior wall 1 (reference)
   Posterior wall 1.451 
(0.746-2.820)
   0.272
Pathology
   Dysplasia 1 (reference)
   Carcinoma 1.755 
(0.905-3.405)
   0.096
Procedure time, min 
   < 60 1 (reference)
   ≥ 60 8.143 
(3.390-19.561)




   Complete resection 1 (reference)
   Incomplete resection 1.842 
(0.799-4.248)
   0.152
Resectability
   En bloc 1 (reference)
   Piecemeal 7.352 
(3.748-14.423)




Univariate analysis Multivariate analysis
OR (95%CI) P  value OR (95%CI) P  value
Tumor size, mm
   < 20 1 (reference)
   ≥ 20 1.938 
(1.151-3.362)




   - 1 (reference)
   + 1.377 
(0.485-3.909) 
   0.547
SM invasion
   - 1 (reference)
   + 0.807 
(0.276-2.358)
   0.695
Location
   Non-upper third 1 (reference)
   Upper third 1.621 
(0.957-2.745)
   0.072
Location
   Non-posterior wall 1 (reference)
   Posterior wall 0.990 
(0.559-1.754)
   0.972
Pathology
   Dysplasia 1 (reference)
   Carcinoma 1.633 
(0.963-2.770)
   0.069
Procedure time, min
   < 60 1 (reference)
   ≥ 60 2.804 
(1.636-4.807)




   Complete resection 1 (reference)




   En bloc 1 (reference)
   Piecemeal 3.771 
(2.040-6.971)
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It is very important that we determine the factors re-
lated to complete resection, because clinically complete 
resection is the ultimate goal of  ESD, and it is closely 
related to tumor recurrence rate after ESD[18,19]. We ana-
lyzed incomplete resection rates according to the tumor 
location, and independent factors related to incomplete 
resection. In multivariate analysis, lesions larger than 20 
mm, posterior wall location, carcinoma and procedure 
time longer than 60 min were statistically significantly 
associated with incomplete resection. Interestingly, the 
significant factor of  location for incomplete resection 
was being in the posterior wall in our study. The poste-
rior wall location makes it technically difficult to use a 
knife during ESD in comparison with the anterior wall 
or lesser curvature locations. Furthermore, in this study, 
almost all cases of  endoscopic resection were per-
formed using a single channel endoscope and because 
this endoscope’s accessory channel opening is oriented 
at the 7 o’clock position, which is the opposite direction 
needed for posterior wall dissections, and makes ESD of  
posterior wall lesions difficult.
During the ESD procedure, serious complications 
such as bleeding or perforation may occur. Risk factors 
for perforation were identified in a recent study by Yoo 
et al[20], who proposed that risk of  perforation is as-
sociated with age, depth of  invasion and length of  the 
procedure. In our study, the perforation rate was signifi-
cantly associated with upper third location. This may be 
due to the fact that lesions in the lower third are easily 
approached and manipulated by endoscopy, and thus it 
is technically easier to perform ESD and there is a lower 
chance of  applying sufficient tension on the gastric wall 
to cause perforation. Another possible reason is that the 
lower or the mid-portion of  the gastric wall is thicker 
than the upper portion of  the stomach.
Previous reports showed that bleeding occurred more 
frequently in the corpus than in the antrum[11,21]. Okada 
et al[22] demonstrated that having a tumor located in the 
mid-third of  the stomach was an independent risk fac-
tor for post-ESD bleeding. However, the relationship 
between tumor location and post-ESD bleeding remains 
controversial to date. In our post-ESD bleeding analy-
sis, location was not a significant factor for post-ESD 
bleeding. Besides tumor location, various factors such 
as the patient’s underlying medical and drug history, the 
endoscopist’s experience and preventive coagulation of  
visible vessels in the resection area after ESD may affect 
post-ESD bleeding. A recent study demonstrated that 
post-ESD bleeding depends on how meticulously coagu-
lation of  visible vessels is performed after dissection[23]. 
Regrettably, we could not analyze the effect of  underly-
ing disease or anti-platelet agents on post-ESD bleeding 
because we had relatively few patients with chronic dis-
ease such as chronic renal failure or cirrhosis, and all the 
patients in our study who underwent ESD discontinued 
anti-platelet agents prior to the procedure.
Limitations of  this study include the fact that it was 
a retrospective single-center study with a limited follow-
up duration. Therefore, there may be a bias according to 
the endoscopist who performed the ESD. In addition, 
we did not include long-term follow-up data concerning 
recurrence, disease-free survival, and overall survival, 
which are important for evaluating the effect of  risk fac-
tors on outcomes. Nevertheless, this study focused on 
outcomes after ESD for gastric tumors with reference 
to therapeutic efficacy and complications according to 
lesion location. Although we did not address long-term 
outcomes, this study revealed that the two main com-
ponents for the feasibility of  ESD, acceptable complete 
resection and complication rates, change according to 
the location of  gastric tumors. In addition, the clinical 
implications of  tumor location were based on large-
volume data. Accordingly, we suggest that attention to 
gastric tumor location, particularly in the upper third 
or posterior wall, during ESD is needed to avoid in-
complete resection and complications. We should also 
explain the possibility of  further surgical treatment after 
ESD to patients with such lesions. Nonetheless, further 
investigations with long-term follow-up data concerning 
the clinical significance of  tumor location are needed to 
support our recommendations.
In conclusion, ESD for gastric tumor is an effective 
and safe therapy. However, endoscopists should recog-
nize the need for more advanced endoscopic techniques 
when performing ESD for lesions located in the up-
per third or posterior wall of  the stomach in order to 




Advances in diagnostic technology and the increasing prevalence of screen-
ing programs have increased the rate of early gastric cancer (EGC) detection. 
EGCs that are confined to the mucosa and lack lymph node metastasis can 
be cured by endoscopic resection, such as endoscopic mucosal resection and 
endoscopic submucosal dissection (ESD).
Research frontiers
Previous studies analyzed tumor location which is anatomically divided into 
three portions (upper, mid, and lower thirds) as a factor related to the clinical 
outcomes of ESD.
Innovations and breakthroughs
In this study, the perforation rate was significantly associated with upper third 
location. This may be due to the fact that lesions at lower third are easily ap-
proached and manipulated by endoscopy, and thus it is technically easier to 
perform ESD and there is a lower chance of applying sufficient tension on the 
gastric wall to cause perforation.
Applications
ESD for gastric tumor is an effective and safe therapy. However, endoscopists 
should recognize the need for more advanced endoscopic techniques when 
performing ESD for lesions located in the upper third or posterior wall of the 
stomach in order to decrease the rate of serious complications and improve 
clinical outcomes.
Peer review
This is an interesting study regarding on the technical aspect of gastric ESD, 
focused on the tumor location. The number of the subjects is large and the 
analysis is simple with clear results.
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